Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) France
Research
Date range: 1 April 2021 - 31 March 2022
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) published between 1 April 2021 - 31 March 2022 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
1 | 0.19 |
Outputs by subject (Share)
Subject | Count | Share |
---|---|---|
Life Sciences | 1 | 0.19 |
Share output for the past 5 years
2016 | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Collaboration
Date range: 1 April 2021 - 31 March 2022
International vs. domestic collaboration by Share
- 100.00% Domestic
- 0.00% International
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) by Share (11 total)
-
Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) and University of Bordeaux
(0.82)
-
Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) and National Institute for Health and Medical Research (INSERM)
(0.39)
-
Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) and Laboratory of Excellence GR-Ex
(0.37)
-
Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) and Laboratory of Rare Diseases, Metabolism and Genetics (MRGM)
(0.37)
-
Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) and TBMCore
(0.25)
-
Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) and French National Centre for Scientific Research (CNRS)
(0.23)
-
Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) and Sorbonne University
(0.21)
-
Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) and University of Montpellier
(0.21)
-
Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) and University of Paris
(0.21)
-
Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) and University of Paris-Sud (UPSud)
(0.21)
Top 10 international collaborators with Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) by Share (0 total)
Relationships
Partner Institutions
Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.